$KBDC
Kayne Anderson BDC Inc Stock $kbdc

$kbdc Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000121390023086801 Filed on November 14, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q4
Revenue	$42.70M	$21.37M
YoY Change		90.22%
Cost Of Revenue	$19.42M	$19.15M
YoY Change
Gross Profit	$23.28M	$22.05M
YoY Change
Gross Profit Margin	54.52%	103.19%
Selling, General & Admin	$845.0K	$681.0K
YoY Change
% of Gross Profit	3.63%	3.09%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$845.0K	$19.83M
YoY Change		114.13%
Operating Profit	$22.43M	$2.222M
YoY Change
Interest Expense	$361.0K	$13.87M
YoY Change		152.02%
% of Operating Profit	1.61%	624.26%
Other Income/Expense, Net
YoY Change
Pretax Income	$22.79M	$13.87M
YoY Change
Income Tax
% Of Pretax Income
Net Earnings	$22.79M	$13.87M
YoY Change
Net Earnings / Revenue	53.39%	64.92%
Basic Earnings Per Share		$0.53
Diluted Earnings Per Share	$0.32	$0.53
COMMON SHARES
Basic Shares Outstanding	41.60M shares	41.51M shares	32.92M shares
Diluted Shares Outstanding		40.50M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$34.07M	$12.38M
YoY Change
Cash & Equivalents	$34.07M	$12.38M	$8.526M
Short-Term Investments
Other Short-Term Assets	$319.0K	$119.0K
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$34.49M	$12.68M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$1.376B	$1.294B	$7.148M
YoY Change	19154.34%	25138.51%	2759.2%
Other Assets
YoY Change
Total Long-Term Assets	$1.389B	$1.308B
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$34.49M	$12.68M
Total Long-Term Assets	$1.389B	$1.308B
Total Assets	$1.424B	$1.321B	$1.194B
YoY Change	19.2%	33.07%	103.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$11.95M	$10.60M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$51.29M	$47.19M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt	$695.8M	$598.0M
YoY Change
Other Long-Term Liabilities	-$6.431M	-$5.289M
YoY Change
Total Long-Term Liabilities	$689.3M	$592.7M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$51.29M	$47.19M
Total Long-Term Liabilities	$689.3M	$592.7M
Total Liabilities	$740.6M	$639.9M	$602.4M
YoY Change	22.95%	36.52%	119.44%
SHAREHOLDERS EQUITY
Retained Earnings	$13.02M	$12.18M	$17.47M
YoY Change	-25.43%	-52.88%	55.6%
Common Stock	$670.0M	$668.5M	$36.00K
YoY Change	1861100.0%	2156503.23%	89.47%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$683.1M	$680.7M	$592.0M
YoY Change
Total Liabilities & Shareholders Equity	$1.424B	$1.321B	$1.194B
YoY Change	19.2%	33.07%	103.66%

Cashflow Statement

Concept	2023 Q4	2023 Q3
OPERATING ACTIVITIES
Net Income	$22.79M	$13.87M
YoY Change
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$53.75M	-$56.30M
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	75.44M	60.16M
YoY Change
NET CHANGE
Cash From Operating Activities	-53.75M	-56.30M
Cash From Investing Activities
Cash From Financing Activities	75.44M	60.16M
Net Change In Cash	21.69M	3.858M
YoY Change
FREE CASH FLOW
Cash From Operating Activities	-$53.75M	-$56.30M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	814-01363
	dei	Entity Registrant Name EntityRegistrantName	Kayne Anderson BDC, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	83-0531326
	dei	Entity Address Address Line1 EntityAddressAddressLine1	811 Main Street
	dei	Entity Address Address Line2 EntityAddressAddressLine2	14th Floor
	dei	Entity Address City Or Town EntityAddressCityOrTown	Houston
	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	77002
	dei	City Area Code CityAreaCode	(713)
	dei	Local Phone Number LocalPhoneNumber	493-2020
	dei	Security12b Title Security12bTitle	None
	dei	No Trading Symbol Flag NoTradingSymbolFlag	true
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	41603665	shares
CY2023Q3	ck0001747172	Longterm Investmentsamortized Cost LongtermInvestmentsamortizedCost	1268376000	usd
CY2022Q4	ck0001747172	Longterm Investmentsamortized Cost LongtermInvestmentsamortizedCost	1147788000	usd
CY2023Q3	us-gaap	Long Term Investments LongTermInvestments	1277603000	usd
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	1165119000	usd
CY2023Q3	ck0001747172	Shortterm Investmentsamortized Cost ShorttermInvestmentsamortizedCost	16628000	usd
CY2022Q4	ck0001747172	Shortterm Investmentsamortized Cost ShorttermInvestmentsamortizedCost	9847000	usd
CY2023Q3	us-gaap	Short Term Investments ShortTermInvestments	16628000	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	9847000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12384000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8526000	usd
CY2023Q3	ck0001747172	Receivable For Principal Payments On Investments ReceivableForPrincipalPaymentsOnInvestments	179000	usd
CY2022Q4	ck0001747172	Receivable For Principal Payments On Investments ReceivableForPrincipalPaymentsOnInvestments	111000	usd
CY2023Q3	us-gaap	Interest Receivable InterestReceivable	13718000	usd
CY2022Q4	us-gaap	Interest Receivable InterestReceivable	10444000	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	119000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	347000	usd
CY2023Q3	us-gaap	Assets Assets	1320631000	usd
CY2022Q4	us-gaap	Assets Assets	1194394000	usd
CY2023Q3	us-gaap	Line Of Credit LineOfCredit	192000000	usd
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	269000000	usd
CY2023Q3	ck0001747172	Unamortized Corporate Credit Facility Issuance Costs UnamortizedCorporateCreditFacilityIssuanceCosts	-1917000	usd
CY2022Q4	ck0001747172	Unamortized Corporate Credit Facility Issuance Costs UnamortizedCorporateCreditFacilityIssuanceCosts	-2517000	usd
CY2023Q3	ck0001747172	Revolving Funding Facility Note RevolvingFundingFacilityNote	306000000	usd
CY2022Q4	ck0001747172	Revolving Funding Facility Note RevolvingFundingFacilityNote	200000000	usd
CY2023Q3	ck0001747172	Unamortized Revolving Funding Facility Issuance Costs UnamortizedRevolvingFundingFacilityIssuanceCosts	-2432000	usd
CY2022Q4	ck0001747172	Unamortized Revolving Funding Facility Issuance Costs UnamortizedRevolvingFundingFacilityIssuanceCosts	-2827000	usd
CY2023Q3	ck0001747172	Subscription Credit Agreement SubscriptionCreditAgreement	25000000	usd
CY2022Q4	ck0001747172	Subscription Credit Agreement SubscriptionCreditAgreement	108000000	usd
CY2023Q3	ck0001747172	Unamortized Subscription Credit Facility Issuance Costs UnamortizedSubscriptionCreditFacilityIssuanceCosts	-37000	usd
CY2022Q4	ck0001747172	Unamortized Subscription Credit Facility Issuance Costs UnamortizedSubscriptionCreditFacilityIssuanceCosts	-65000	usd
CY2023Q3	ck0001747172	Senior Unsecured Notes SeniorUnsecuredNotes	75000000	usd
CY2023Q3	ck0001747172	Unamortized Notes Issuance Costs UnamortizedNotesIssuanceCosts	-903000	usd
CY2022Q4	ck0001747172	Payable For Investments Purchased PayableForInvestmentsPurchased	956000	usd
CY2023Q3	us-gaap	Distribution Payable DistributionPayable	21999000	usd
CY2022Q4	us-gaap	Distribution Payable DistributionPayable	15428000	usd
CY2023Q3	us-gaap	Management Fee Payable ManagementFeePayable	2905000	usd
CY2022Q4	us-gaap	Management Fee Payable ManagementFeePayable	2415000	usd
CY2023Q3	us-gaap	Incentive Fee Payable IncentiveFeePayable	11692000	usd
CY2022Q4	us-gaap	Incentive Fee Payable IncentiveFeePayable	4762000	usd
CY2023Q3	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	10598000	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	7201000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	639905000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	602353000	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	41506935	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41506935	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	35879291	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	35879291	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	42000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	36000	usd
CY2023Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	668505000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	574540000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	12179000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	17465000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	680726000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	592041000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1320631000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1194394000	usd
CY2023Q3	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	16.4
CY2022Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	16.5
CY2023Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	41041000	usd
CY2022Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	20494000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	117960000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	45386000	usd
CY2023Q3	us-gaap	Dividend Income Operating DividendIncomeOperating	156000	usd
	us-gaap	Dividend Income Operating DividendIncomeOperating	349000	usd
CY2023Q3	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	41197000	usd
CY2022Q3	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	20494000	usd
	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	118309000	usd
	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	45386000	usd
CY2023Q3	us-gaap	Management Fee Expense ManagementFeeExpense	2905000	usd
CY2022Q3	us-gaap	Management Fee Expense ManagementFeeExpense	1908000	usd
	us-gaap	Management Fee Expense ManagementFeeExpense	8438000	usd
	us-gaap	Management Fee Expense ManagementFeeExpense	4732000	usd
CY2023Q3	us-gaap	Incentive Fee Expense IncentiveFeeExpense	2371000	usd
CY2022Q3	us-gaap	Incentive Fee Expense IncentiveFeeExpense	1230000	usd
	us-gaap	Incentive Fee Expense IncentiveFeeExpense	6929000	usd
	us-gaap	Incentive Fee Expense IncentiveFeeExpense	2960000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	13871000	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	5504000	usd
	us-gaap	Interest Expense InterestExpense	38396000	usd
	us-gaap	Interest Expense InterestExpense	11325000	usd
CY2023Q3	us-gaap	Professional Fees ProfessionalFees	189000	usd
CY2022Q3	us-gaap	Professional Fees ProfessionalFees	166000	usd
	us-gaap	Professional Fees ProfessionalFees	482000	usd
	us-gaap	Professional Fees ProfessionalFees	466000	usd
CY2023Q3	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	147000	usd
CY2022Q3	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	107000	usd
	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	464000	usd
	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	321000	usd
	us-gaap	Noninterest Expense Offering Cost NoninterestExpenseOfferingCost	29000	usd
CY2023Q3	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	345000	usd
CY2022Q3	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	345000	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	1216000	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	961000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	19828000	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	9260000	usd
	us-gaap	Operating Expenses OperatingExpenses	55925000	usd
	us-gaap	Operating Expenses OperatingExpenses	20794000	usd
CY2023Q3	us-gaap	Net Investment Income NetInvestmentIncome	21369000	usd
CY2022Q3	us-gaap	Net Investment Income NetInvestmentIncome	11234000	usd
	us-gaap	Net Investment Income NetInvestmentIncome	62384000	usd
	us-gaap	Net Investment Income NetInvestmentIncome	24592000	usd
CY2022Q3	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	47000	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	70000	usd
CY2022Q3	ck0001747172	Realized Investment Gains Losses Net RealizedInvestmentGainsLossesNet	47000	usd
	ck0001747172	Realized Investment Gains Losses Net RealizedInvestmentGainsLossesNet	70000	usd
CY2023Q3	ck0001747172	Net Change In Unrealized Gains Losses Investments NetChangeInUnrealizedGainsLossesInvestments	-7497000	usd
CY2022Q3	ck0001747172	Net Change In Unrealized Gains Losses Investments NetChangeInUnrealizedGainsLossesInvestments	3317000	usd
	ck0001747172	Net Change In Unrealized Gains Losses Investments NetChangeInUnrealizedGainsLossesInvestments	-8103000	usd
	ck0001747172	Net Change In Unrealized Gains Losses Investments NetChangeInUnrealizedGainsLossesInvestments	3127000	usd
CY2023Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-7497000	usd
CY2022Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	3317000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-8103000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	3127000	usd
CY2023Q3	ck0001747172	Net Realized And Unrealized Gainloss On Investment NetRealizedAndUnrealizedGainlossOnInvestment	-7497000	usd
CY2022Q3	ck0001747172	Net Realized And Unrealized Gainloss On Investment NetRealizedAndUnrealizedGainlossOnInvestment	3364000	usd
	ck0001747172	Net Realized And Unrealized Gainloss On Investment NetRealizedAndUnrealizedGainlossOnInvestment	-8103000	usd
	ck0001747172	Net Realized And Unrealized Gainloss On Investment NetRealizedAndUnrealizedGainlossOnInvestment	3197000	usd
CY2023Q3	ck0001747172	Investment Company Net Asset From Operations Increase Decrease InvestmentCompanyNetAssetFromOperationsIncreaseDecrease	13872000	usd
CY2022Q3	ck0001747172	Investment Company Net Asset From Operations Increase Decrease InvestmentCompanyNetAssetFromOperationsIncreaseDecrease	14598000	usd
	ck0001747172	Investment Company Net Asset From Operations Increase Decrease InvestmentCompanyNetAssetFromOperationsIncreaseDecrease	54281000	usd
	ck0001747172	Investment Company Net Asset From Operations Increase Decrease InvestmentCompanyNetAssetFromOperationsIncreaseDecrease	27789000	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.53
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.38
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.62
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.98
CY2023Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.34
CY2022Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.49
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.41
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.1
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40499327	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29530036	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	38461385	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25177005	shares
CY2023Q3	us-gaap	Net Investment Income NetInvestmentIncome	21369000	usd
CY2022Q3	us-gaap	Net Investment Income NetInvestmentIncome	11234000	usd
	us-gaap	Net Investment Income NetInvestmentIncome	62384000	usd
	us-gaap	Net Investment Income NetInvestmentIncome	24592000	usd
CY2022Q3	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	47000	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	70000	usd
CY2023Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-7497000	usd
CY2022Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	3317000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-8103000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	3127000	usd
CY2023Q3	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	13872000	usd
CY2022Q3	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	14598000	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	54281000	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	27789000	usd
CY2023Q3	ck0001747172	Investment Company Distribution To Shareholders InvestmentCompanyDistributionToShareholders	21999000	usd
CY2022Q3	ck0001747172	Investment Company Distribution To Shareholders InvestmentCompanyDistributionToShareholders	7065000	usd
	ck0001747172	Investment Company Distribution To Shareholders InvestmentCompanyDistributionToShareholders	59567000	usd
	ck0001747172	Investment Company Distribution To Shareholders InvestmentCompanyDistributionToShareholders	13168000	usd
CY2023Q3	ck0001747172	Net Decrease In Net Assets Resulting From Stockholder Distributions NetDecreaseInNetAssetsResultingFromStockholderDistributions	-21999000	usd
CY2022Q3	ck0001747172	Net Decrease In Net Assets Resulting From Stockholder Distributions NetDecreaseInNetAssetsResultingFromStockholderDistributions	-7065000	usd
	ck0001747172	Net Decrease In Net Assets Resulting From Stockholder Distributions NetDecreaseInNetAssetsResultingFromStockholderDistributions	-59567000	usd
	ck0001747172	Net Decrease In Net Assets Resulting From Stockholder Distributions NetDecreaseInNetAssetsResultingFromStockholderDistributions	-13168000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	40575000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	125000000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	90575000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	193582000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	1352000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	1431000	usd
	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	3396000	usd
	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	3555000	usd
CY2023Q3	ck0001747172	Net Increase In Net Assets Resulting From Capital Share Transactions NetIncreaseInNetAssetsResultingFromCapitalShareTransactions	41927000	usd
CY2022Q3	ck0001747172	Net Increase In Net Assets Resulting From Capital Share Transactions NetIncreaseInNetAssetsResultingFromCapitalShareTransactions	126431000	usd
	ck0001747172	Net Increase In Net Assets Resulting From Capital Share Transactions NetIncreaseInNetAssetsResultingFromCapitalShareTransactions	93971000	usd
	ck0001747172	Net Increase In Net Assets Resulting From Capital Share Transactions NetIncreaseInNetAssetsResultingFromCapitalShareTransactions	197137000	usd
CY2023Q3	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	33800000	usd
CY2022Q3	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	133964000	usd
	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	88685000	usd
	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	211758000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	646926000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	389763000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	592041000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	311969000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	680726000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	523727000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	680726000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	523727000	usd
	us-gaap	Profit Loss ProfitLoss	54281000	usd
	us-gaap	Profit Loss ProfitLoss	27789000	usd
	ck0001747172	Net Realizedgainslosses On Investments NetRealizedgainslossesOnInvestments	70000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-8103000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	3127000	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	6760000	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	3287000	usd
	ck0001747172	Purchases Of Shortterm Investments Net PurchasesOfShorttermInvestmentsNet	-6781000	usd
	ck0001747172	Purchases Of Shortterm Investments Net PurchasesOfShorttermInvestmentsNet	-1084000	usd
	ck0001747172	Purchases Of Portfolio Investments PurchasesOfPortfolioInvestments	217836000	usd
	ck0001747172	Purchases Of Portfolio Investments PurchasesOfPortfolioInvestments	468799000	usd
	ck0001747172	Proceeds From Sales Of Investments And Principal Repayments ProceedsFromSalesOfInvestmentsAndPrincipalRepayments	105319000	usd
	ck0001747172	Proceeds From Sales Of Investments And Principal Repayments ProceedsFromSalesOfInvestmentsAndPrincipalRepayments	89694000	usd
	ck0001747172	Paidinkind Interest From Portfolio Investments PaidinkindInterestFromPortfolioInvestments	1310000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1936000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1533000	usd
	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	3274000	usd
	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	5820000	usd
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	-29000	usd
	ck0001747172	Increasedecrease In Receivable For Principal Payments On Investments IncreasedecreaseInReceivableForPrincipalPaymentsOnInvestments	68000	usd
	ck0001747172	Increasedecrease In Receivable For Principal Payments On Investments IncreasedecreaseInReceivableForPrincipalPaymentsOnInvestments	273000	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-228000	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	9000	usd
	us-gaap	Increase Decrease In Payable For Investment Purchased IncreaseDecreaseInPayableForInvestmentPurchased	-956000	usd
	us-gaap	Increase Decrease In Management Fee Payable IncreaseDecreaseInManagementFeePayable	490000	usd
	us-gaap	Increase Decrease In Management Fee Payable IncreaseDecreaseInManagementFeePayable	956000	usd
	us-gaap	Increase Decrease In Incentive Fee Payable IncreaseDecreaseInIncentiveFeePayable	6930000	usd
	us-gaap	Increase Decrease In Incentive Fee Payable IncreaseDecreaseInIncentiveFeePayable	2960000	usd
	ck0001747172	Increasedecrease In Accrued Organizational And Offering Costs Net IncreasedecreaseInAccruedOrganizationalAndOfferingCostsNet	-6000	usd
	ck0001747172	Increasedecrease In Accrued Other General And Administrative Expenses IncreasedecreaseInAccruedOtherGeneralAndAdministrativeExpenses	3397000	usd
	ck0001747172	Increasedecrease In Accrued Other General And Administrative Expenses IncreasedecreaseInAccruedOtherGeneralAndAdministrativeExpenses	2096000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-56301000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-357418000	usd
	ck0001747172	Borrowingspayments On Corporate Credit Facility Net BorrowingspaymentsOnCorporateCreditFacilityNet	77000000	usd
	ck0001747172	Borrowingspayments On Corporate Credit Facility Net BorrowingspaymentsOnCorporateCreditFacilityNet	-202000000	usd
	ck0001747172	Borrowings On Revolving Funding Facility Net BorrowingsOnRevolvingFundingFacilityNet	106000000	usd
	ck0001747172	Borrowings On Revolving Funding Facility Net BorrowingsOnRevolvingFundingFacilityNet	200000000	usd
	us-gaap	Proceeds From Repayments Of Other Debt ProceedsFromRepaymentsOfOtherDebt	-162000000	usd
	ck0001747172	Borrowings On Subscription And Credit Agreement Net BorrowingsOnSubscriptionAndCreditAgreementNet	-83000000	usd
	ck0001747172	Borrowings On Subscription And Credit Agreement Net BorrowingsOnSubscriptionAndCreditAgreementNet	-43000000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	1816000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	5700000	usd
	us-gaap	Payments Of Capital Distribution PaymentsOfCapitalDistribution	49600000	usd
	us-gaap	Payments Of Capital Distribution PaymentsOfCapitalDistribution	14228000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	90575000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	193582000	usd
	ck0001747172	Proceeds From Issuance Of Notes ProceedsFromIssuanceOfNotes	75000000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	60159000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	370654000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	3858000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	13236000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8526000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2035000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12384000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15271000	usd
	us-gaap	Interest Paid Net InterestPaidNet	32882000	usd
	us-gaap	Interest Paid Net InterestPaidNet	8168000	usd
	ck0001747172	Noncash Financing Activities Not Included Herein Consisted Of Reinvestment Of Dividends NoncashFinancingActivitiesNotIncludedHereinConsistedOfReinvestmentOfDividends	3396000	usd
	ck0001747172	Noncash Financing Activities Not Included Herein Consisted Of Reinvestment Of Dividends NoncashFinancingActivitiesNotIncludedHereinConsistedOfReinvestmentOfDividends	3555000	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 1. Organization</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Organization</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Kayne Anderson BDC, Inc. (the “Company”) is an externally managed, closed-end, non-diversified management investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). In addition, for U.S. federal income tax purposes, the Company intends to qualify as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company was formed as a Delaware corporation to make investments in middle-market companies and commenced operations on February 5, 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of September 30, 2023, the Company has entered into subscription agreements with investors for an aggregate capital commitment of $887,003 to purchase shares of the Company’s common stock. See Note 11 – Subsequent Events.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">KA Credit Advisors, LLC (the “Advisor”) is an affiliate of Kayne Anderson Capital Advisors, L.P. (“Kayne Anderson”), a prominent alternative investment management firm. The Advisor and Kayne Anderson are registered with the United States Securities and Exchange Commission (the “SEC”) under the Investment Advisory Act of 1940, as amended. Subject to the overall supervision of the Company’s board of directors (the “Board”), the Advisor is responsible for originating prospective investments, conducting research and due diligence investigations on potential investments, analyzing investment opportunities, negotiating and structuring investments, determining the value of its investments and monitoring its investments and portfolio companies on an ongoing basis. The Board consists of seven directors, four of whom are independent.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s investment objective is to generate current income and, to a lesser extent, capital appreciation primarily through debt investments in middle-market companies.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company conducts private offerings of its Common Stock to investors in reliance on exemptions from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”). At the closing of any private offering, each investor will make a capital commitment (a “Capital Commitment”) to purchase shares of its common stock pursuant to a subscription agreement entered into with the Company. Investors will be required to fund drawdowns to purchase shares of common stock up to the amount of their respective Capital Commitments each time the Company delivers a notice to the investors. Following the initial closing of the private offering (the “Initial Closing”) on February 5, 2021 and prior to any Liquidity Event (as defined below), the Advisor may, in its sole discretion, permit additional closings of the private offering. A “Liquidity Event” is defined as (a) an initial public offering of shares of common stock (the “Initial Public Offering”) or the listing of shares of common stock on an exchange (together with the Initial Public Offering, an “Exchange Listing”), (b) the sale of the Company or (c) a disposition of the Company’s investments and distribution of the net proceeds (after repayment of borrowed funds or other forms of leverage) to the Company’s investors.</p>
CY2023Q3	us-gaap	Investment Company Financial Commitment To Investee Future Amount InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount	887003000	usd
CY2023Q3	ck0001747172	Non Qualifying Assets NonQualifyingAssets	68159000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">C.<i> Use of Estimates</i>—the preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of income and expenses during the period. Actual results could differ materially from those estimates.</p>
	ck0001747172	Third Party Valuation Percentage ThirdPartyValuationPercentage	0.25	pure
	us-gaap	Dividends Paidinkind DividendsPaidinkind	1310000	usd
	ck0001747172	Aggregate Interest Income AggregateInterestIncome	0.011	pure
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	1165119000	usd
	ck0001747172	Distributions Percentage DistributionsPercentage	0.90	pure
	us-gaap	Quarterly Financial Information Income Taxes Significant Variation Description QuarterlyFinancialInformationIncomeTaxesSignificantVariationDescription	All RICs are subject to a non-deductible 4% excise tax on income that is not distributed on a timely basis in accordance with the calendar year distribution requirements. To avoid the tax, the Company must distribute during each calendar year an amount at least equal to the sum of (i) 98% of its ordinary income for the calendar year, (ii) 98.2% of its net capital gains for the one-year period ending on December 31, the last day of our taxable year, and (iii) undistributed amounts from previous years on which the Company paid no U.S. federal income tax.
	ck0001747172	Base Management Fee Annual Rate BaseManagementFeeAnnualRate	0.015	pure
	ck0001747172	Fair Market Value In Percentage FairMarketValueInPercentage	0.01	pure
CY2023Q3	us-gaap	Management Fee Expense ManagementFeeExpense	2905000	usd
CY2022Q3	us-gaap	Management Fee Expense ManagementFeeExpense	1908000	usd
	us-gaap	Management Fee Expense ManagementFeeExpense	8438000	usd
	us-gaap	Management Fee Expense ManagementFeeExpense	4732000	usd
	us-gaap	Investment Company Incentive Fee To Average Net Assets InvestmentCompanyIncentiveFeeToAverageNetAssets	0.015	pure
	us-gaap	Investment Company Total Return After Incentive Fees InvestmentCompanyTotalReturnAfterIncentiveFees	0.06	pure
	us-gaap	Incentive Fee Description IncentiveFeeDescription	●Prior to an Exchange Listing: 100% of our pre-incentive fee net investment income for the immediately preceding calendar quarter in excess of 1.50% of the Company’s NAV at the end of the immediately preceding calendar quarter until the Advisor has received 10% of the total pre-incentive fee net income for that calendar quarter and, for pre-incentive fee net investment income in excess of 1.6667%, 10% of all remaining pre-incentive fee net investment income for that quarter. ● After an Exchange Listing: 100% of the Company’s pre-incentive fee net investment income for the immediately preceding calendar quarter in excess of 1.50% of the Company’s NAV at the end of the immediately preceding calendar quarter until the Advisor has received 15% of the total pre-incentive fee net income for that calendar quarter and, for pre-incentive fee net investment income in excess of 1.7647%, 15% of all remaining pre-incentive fee net investment income for that quarter.
CY2022Q3	us-gaap	Incentive Fee Expense IncentiveFeeExpense	1230000	usd
	us-gaap	Incentive Fee Expense IncentiveFeeExpense	6929000	usd
	ck0001747172	Incentive Fee Expense Excluding Capital Gains IncentiveFeeExpenseExcludingCapitalGains	2960000	usd
CY2022Q4	ck0001747172	Non Qualifying Assets NonQualifyingAssets	45901000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	219146000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	-105319000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	-8103000	usd
	ck0001747172	Longterm Investments Fair Value Percentage LongtermInvestmentsFairValuePercentage	1	pure
CY2022	ck0001747172	Longterm Investments Fair Value Percentage LongtermInvestmentsFairValuePercentage	1	pure
CY2023Q3	us-gaap	Investments Investments	1269539000	usd
CY2023Q3	us-gaap	Equity Method Investments Fair Value Disclosure EquityMethodInvestmentsFairValueDisclosure	8064000	usd
CY2023Q3	us-gaap	Short Term Investments ShortTermInvestments	16628000	usd
CY2023Q3	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	1294231000	usd
CY2022Q4	us-gaap	Investments Investments	1157971000	usd
CY2022Q4	us-gaap	Equity Method Investments Fair Value Disclosure EquityMethodInvestmentsFairValueDisclosure	7148000	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	9847000	usd
CY2022Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	1174966000	usd
CY2023Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	1283951000	usd
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	40482000	usd
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	-41776000	usd
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	-7497000	usd
CY2023Q3	ck0001747172	Fair Value Measurement With Unobservable Input Reconciliation Recurring Basis Net Accretion Of Discount On Investments FairValueMeasurementWithUnobservableInputReconciliationRecurringBasisNetAccretionOfDiscountOnInvestments	2443000	usd
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	1277603000	usd
CY2022Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	717964000	usd
CY2022Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	287348000	usd
CY2022Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	-45917000	usd
CY2022Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	3317000	usd
CY2022Q3	us-gaap	Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	47000	usd
CY2022Q3	ck0001747172	Fair Value Measurement With Unobservable Input Reconciliation Recurring Basis Net Accretion Of Discount On Investments FairValueMeasurementWithUnobservableInputReconciliationRecurringBasisNetAccretionOfDiscountOnInvestments	1275000	usd
CY2022Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	964034000	usd
	ck0001747172	Fair Value Measurement With Unobservable Input Reconciliation Recurring Basis Net Accretion Of Discount On Investments FairValueMeasurementWithUnobservableInputReconciliationRecurringBasisNetAccretionOfDiscountOnInvestments	6760000	usd
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	1277603000	usd
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	578445000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	468799000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	-89694000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	3127000	usd
	us-gaap	Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	70000	usd
	ck0001747172	Fair Value Measurement With Unobservable Input Reconciliation Recurring Basis Net Accretion Of Discount On Investments FairValueMeasurementWithUnobservableInputReconciliationRecurringBasisNetAccretionOfDiscountOnInvestments	3287000	usd
CY2022Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	964034000	usd
CY2023Q3	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	125000000	usd
	us-gaap	Line Of Credit Facility Commitment Fee Percentage LineOfCreditFacilityCommitmentFeePercentage	0.0025	pure
	ck0001747172	Extension Fee ExtensionFee	0.0005	pure
	ck0001747172	Debt Total Commitment DebtTotalCommitment	400000000	usd
	us-gaap	Long Term Debt Average Amount Outstanding LongTermDebtAverageAmountOutstanding	192000000	usd
CY2022Q1	us-gaap	Other Loans Payable OtherLoansPayable	150000000	usd
CY2023Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	75000000	usd
CY2023Q3	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	903000	usd
CY2023Q3	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	75625000	usd
CY2023Q3	ck0001747172	Debt Weighted Average Interest Rate1 DebtWeightedAverageInterestRate1	0.0871	pure
	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.01	pure
	us-gaap	Debt Instrument Redemption Price Percentage Of Principal Amount Redeemed DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed	0.015	pure
CY2023Q3	ck0001747172	Aggregate Interest Threshold AggregateInterestThreshold	0.02	pure
CY2023Q3	ck0001747172	Asset Coverage Ratio AssetCoverageRatio	1.50	pure
	us-gaap	Line Of Credit Facility Periodic Payment Principal LineOfCreditFacilityPeriodicPaymentPrincipal	1055000000	usd
	us-gaap	Line Of Credit Facility Average Outstanding Amount LineOfCreditFacilityAverageOutstandingAmount	598000000	usd
CY2023Q3	ck0001747172	Line Of Credit Available Amount LineOfCreditAvailableAmount	328324000	usd
CY2023Q3	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	592711000	usd
CY2022	us-gaap	Line Of Credit Facility Periodic Payment Principal LineOfCreditFacilityPeriodicPaymentPrincipal	875000000	usd
CY2022	us-gaap	Line Of Credit Facility Average Outstanding Amount LineOfCreditFacilityAverageOutstandingAmount	577000000	usd
CY2022Q4	ck0001747172	Line Of Credit Available Amount LineOfCreditAvailableAmount	169793000	usd
CY2022Q4	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	571591000	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	54281000	usd
CY2023Q3	us-gaap	Interest Expense Other InterestExpenseOther	13119000	usd
CY2022Q3	us-gaap	Interest Expense Other InterestExpenseOther	4976000	usd
CY2023Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	752000	usd
CY2022Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	528000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	13871000	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	5504000	usd
CY2023Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	617598000	usd
CY2022Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	410146000	usd
	us-gaap	Interest Expense Other InterestExpenseOther	36460000	usd
	us-gaap	Interest Expense Other InterestExpenseOther	9792000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1936000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1533000	usd
	us-gaap	Interest Expense InterestExpense	38396000	usd
	us-gaap	Interest Expense InterestExpense	11325000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	625421000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	312423000	usd
CY2023Q3	us-gaap	Shares Issued SharesIssued	5422524	shares
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	90575000	usd
CY2022Q3	us-gaap	Shares Issued SharesIssued	11858122	shares
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	193582000	usd
	ck0001747172	Aggregate Capital Commitment AggregateCapitalCommitment	887003000	usd
CY2023Q3	us-gaap	Other Commitment OtherCommitment	228709000	usd
CY2022Q3	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	14598000	usd
CY2023Q3	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	1.53
CY2022Q3	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	0.56
	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	205120	shares
	ck0001747172	Stock Issued During Period Value Dividends Reinvestment Plan StockIssuedDuringPeriodValueDividendsReinvestmentPlan	3396000	usd
	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	218941	shares
	ck0001747172	Stock Issued During Period Value Dividends Reinvestment Plan StockIssuedDuringPeriodValueDividendsReinvestmentPlan	3555000	usd
CY2023Q3	ck0001747172	Unfunded Commitments UnfundedCommitments	109130000	usd
CY2022Q4	ck0001747172	Unfunded Commitments UnfundedCommitments	149338000	usd
CY2023Q3	ck0001747172	Unfunded Commitments UnfundedCommitments	109130000	usd
CY2022Q4	ck0001747172	Unfunded Commitments UnfundedCommitments	149338000	usd
CY2023Q3	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	13872000	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	27789000	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40499327	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29530036	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	38461385	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25177005	shares
CY2023Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.34
CY2022Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.49
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.41
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.1
CY2022Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	16.5
CY2021Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	16.22
	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	1.62
	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	0.98
	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	-0.19
	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	0.09
	us-gaap	Investment Company Investment Income Loss From Operations Per Share InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare	1.43
	us-gaap	Investment Company Investment Income Loss From Operations Per Share InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare	1.07
	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	1.53
	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	0.56
	ck0001747172	Net Decrease In Net Assets Resulting From Distributions Subtotal NetDecreaseInNetAssetsResultingFromDistributionsSubtotal	-1.53
	ck0001747172	Net Decrease In Net Assets Resulting From Distributions Subtotal NetDecreaseInNetAssetsResultingFromDistributionsSubtotal	-0.56
CY2023Q3	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	16.4
CY2022Q3	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	16.73
CY2023Q3	us-gaap	Shares Outstanding SharesOutstanding	41506935	shares
CY2022Q3	us-gaap	Shares Outstanding SharesOutstanding	31304965	shares
CY2023Q3	us-gaap	Net Regulatory Assets NetRegulatoryAssets	680726000	usd
CY2022Q3	us-gaap	Net Regulatory Assets NetRegulatoryAssets	523727000	usd
	ck0001747172	Weightedaverage Shares Outstandingin Shares WeightedaverageSharesOutstandinginShares	38461385	shares
	ck0001747172	Weightedaverage Shares Outstandingin Shares WeightedaverageSharesOutstandinginShares	25177005	shares
	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.089	pure
	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.067	pure
	us-gaap	Investment Company Portfolio Turnover InvestmentCompanyPortfolioTurnover	0.085	pure
	us-gaap	Investment Company Portfolio Turnover InvestmentCompanyPortfolioTurnover	0.125	pure
	ck0001747172	Ratio Of Operating Expenses To Average Net Assets RatioOfOperatingExpensesToAverageNetAssets	0.119	pure
	ck0001747172	Ratio Of Operating Expenses To Average Net Assets RatioOfOperatingExpensesToAverageNetAssets	0.069	pure
	us-gaap	Investment Company Investment Income Loss Ratio InvestmentCompanyInvestmentIncomeLossRatio	0.133	pure
	us-gaap	Investment Company Investment Income Loss Ratio InvestmentCompanyInvestmentIncomeLossRatio	0.082	pure
CY2023Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0
CY2022Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.03
CY2022Q4	ck0001747172	Senior Unsecured Notes SeniorUnsecuredNotes		usd
CY2022Q4	ck0001747172	Unamortized Notes Issuance Costs UnamortizedNotesIssuanceCosts		usd
CY2023Q3	ck0001747172	Payable For Investments Purchased PayableForInvestmentsPurchased		usd
CY2023Q3	us-gaap	Noninterest Expense Offering Cost NoninterestExpenseOfferingCost		usd
CY2022Q3	us-gaap	Noninterest Expense Offering Cost NoninterestExpenseOfferingCost		usd
	us-gaap	Noninterest Expense Offering Cost NoninterestExpenseOfferingCost		usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.34
CY2022Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.49
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25177005	shares
	ck0001747172	Net Realizedgainslosses On Investments NetRealizedgainslossesOnInvestments		usd
	ck0001747172	Paidinkind Interest From Portfolio Investments PaidinkindInterestFromPortfolioInvestments		usd
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges		usd
	us-gaap	Increase Decrease In Payable For Investment Purchased IncreaseDecreaseInPayableForInvestmentPurchased		usd
	ck0001747172	Increasedecrease In Accrued Organizational And Offering Costs Net IncreasedecreaseInAccruedOrganizationalAndOfferingCostsNet		usd
	us-gaap	Proceeds From Repayments Of Other Debt ProceedsFromRepaymentsOfOtherDebt		usd
	ck0001747172	Proceeds From Issuance Of Notes ProceedsFromIssuanceOfNotes		usd
	us-gaap	Dividends Paidinkind DividendsPaidinkind		usd
CY2023Q3	ck0001747172	Capital Gains CapitalGains		usd
CY2022Q3	ck0001747172	Capital Gains CapitalGains		usd
	ck0001747172	Capital Gains CapitalGains		usd
	ck0001747172	Capital Gains CapitalGains		usd
CY2023Q3	us-gaap	Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss		usd
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3		usd
CY2022Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3		usd
	us-gaap	Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss		usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3		usd
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40499327	shares
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.10
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.41
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001747172

Files In Submission

Name	View Source	Status
0001213900-23-086801-index-headers.html	Edgar Link	pending
0001213900-23-086801-index.html	Edgar Link	pending
0001213900-23-086801.txt	Edgar Link	pending
0001213900-23-086801-xbrl.zip	Edgar Link	pending
ck0001747172-20230930.xsd	Edgar Link	pending
f10q0923ex31-1_kayneand.htm	Edgar Link	pending
f10q0923ex31-2_kayneand.htm	Edgar Link	pending
f10q0923ex32-1_kayneand.htm	Edgar Link	pending
f10q0923ex32-2_kayneand.htm	Edgar Link	pending
f10q0923_kayneand.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
f10q0923_kayneand_htm.xml	Edgar Link	completed
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ck0001747172-20230930_pre.xml	Edgar Link	unprocessable
ck0001747172-20230930_lab.xml	Edgar Link	unprocessable
ck0001747172-20230930_cal.xml	Edgar Link	unprocessable
ck0001747172-20230930_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KBDC
Kayne Anderson BDC Inc Stock $kbdc

2023 Q4 Form 10-Q Financial Statement

#000121390023086801 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KBDC Kayne Anderson BDC Inc Stock $kbdc

2023 Q4 Form 10-Q Financial Statement

#000121390023086801 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KBDC
Kayne Anderson BDC Inc Stock $kbdc